Epigenetic silencing of glutaminase 2 in human liver and colon cancers. - Wikidata - awgldk - TriplyDB

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

http://www.wikidata.org/entity/Q35065476

about

From Krebs to clinic: glutamine metabolism to cancer therapy.Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients.Hippo-YAP signaling pathway: A new paradigm for cancer therapy.Targeting amino acid metabolism for cancer therapy.Glutamine Addiction In Gliomas.The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.Glutamine Metabolism in Gliomas.Targeting Glutamine Metabolism for Cancer Treatment.Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.

P2860

Q33834498-7A6115BE-6978-41DA-9898-1AF13D456349 Q35776498-7F416BE8-E82D-41EF-A166-335652D7595A Q36799987-CD4E0094-8FA8-4925-AC9D-A3D1098DDCDD Q38231786-32D7C6C4-28FF-4057-BCEA-2978DFEB2AF6 Q39042260-5729B0BD-423D-4C6E-B540-910AEB6BB693 Q39172398-8384D5BB-88B6-4CBF-9391-BF6C39999F38 Q47326513-3F6810AB-DA29-4C8C-82D8-98807D178641 Q48417468-4E4B253F-040B-4F3A-82B4-485673729599 Q49632469-20E155B1-5FFC-4B01-AF56-EBB8388ACE5E Q55459904-D3822720-6A41-41A0-8F1D-1691D14232CF

P2860

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

http://www.wikidata.org/entity/Q35065476

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@ast

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@en

type

label

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@ast

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@en

prefLabel

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@ast

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@en

P1433

Q35065476-DF0F7980-C287-43A1-B34D-8618457BEB0E

P1476

Q35065476-3C220BAB-77F8-4D3B-8D12-410132885F46

P2093

Q35065476-160F1AAC-E9BE-4FD8-A139-9849B58C9BDD

Q35065476-2238C00C-02F6-4389-9FA7-DA8E5D566D1B

Q35065476-55AAB90A-9878-4152-BF16-4B55A9FEF6BC

Q35065476-A87E4514-893A-46D3-976A-9FDE0066244F

Q35065476-AB651686-94D9-417B-A661-7FE90603FF82

Q35065476-B77B25AE-B324-4659-BF6A-24B61AF3E585

Q35065476-FEB01E81-0FB2-43C3-94DD-ABD3BDCC821C

P2860

Q35065476-0F47FCC3-9ABD-4855-840A-6334FAC296DE

Q35065476-27D415C4-8AA0-45E9-B03D-4608A22D30D3

Q35065476-290BF869-F0AA-4D05-B994-3C3388DEEAC7

Q35065476-32AD47EB-7756-4634-A4FD-C0ED8BE5C3DE

Q35065476-347F4C35-26C7-4A2C-8BE8-EF9FA29ACC03

Q35065476-39D6C1B2-924C-4782-B8F9-272006228604

Q35065476-3E0A905C-FB7A-4E07-B131-09A4A410352F

Q35065476-4B618201-63AC-4F2C-98DF-7703002543E3

Q35065476-53CA897C-F843-4AD0-A6A3-BBEA5BBFC971

Q35065476-55851B95-6114-43E1-9668-3E374D829859

P2888

Q35065476-21E3C078-B0D3-4272-BCED-AB967A78372B

P304

Q35065476-9791C478-2EDC-4929-A1B2-6B821604DEFE

P31

Q35065476-FB817A27-E302-4029-9712-AB5AED21E660

P356

Q35065476-92064C3E-D6AB-4A6D-858A-83302977D4A9

P407

Q35065476-FE591744-0340-4323-8669-3A3EBDB52403

P478

Q35065476-CBFA434A-FFD2-4833-8A2B-739EB483A54C

P50

Q35065476-F3BB2DA4-05F6-46A1-B59F-C52F4573A178

P577

Q35065476-89B823AB-1778-4658-A400-7B688526566F

P5875

Q35065476-ABFC2378-48BD-4DE3-ADC1-A5B6E0243372

P6179

Q35065476-29ED05D8-F7F6-49F3-9586-D2C2BBF1E86B

P698

Q35065476-472139C4-1DA1-4C23-B4C6-2B73D6CD7089

P932

Q35065476-6A5F07C6-8C12-4C53-AD50-192421926A0F

P356

1471-2407-13-601

P1433

P1476

Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

@en

P2093

Cheng Wang

http://www.w3.org/2001/XMLSchema#string

Dajing Xia

http://www.w3.org/2001/XMLSchema#string

Jianbin Zhang

http://www.w3.org/2001/XMLSchema#string

Jianping Cao

http://www.w3.org/2001/XMLSchema#string

Liting Chen

http://www.w3.org/2001/XMLSchema#string

Mingquan Chen

http://www.w3.org/2001/XMLSchema#string

Ying Zhong

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma

The fundamental role of epigenetic events in cancer

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

The epigenomics of cancer

Functions of DNA methylation: islands, start sites, gene bodies and beyond

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

P2888

1471-2407-13-601

P304

601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-601

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259316104

http://www.w3.org/2001/XMLSchema#string

P6179

1040360331

http://www.w3.org/2001/XMLSchema#string

P698

24330717

http://www.w3.org/2001/XMLSchema#string

P932

3878668

http://www.w3.org/2001/XMLSchema#string